Bristol-Myers Squibb Company Receives The LEAD Award From The US Oncology Network
HOUSTON--(BUSINESS WIRE)--Today, The US Oncology Network, one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care, presented Bristol-Myers Squibb (BMS) with the inaugural LEAD Award during The Network’s Joint Fall Pharmacy & Therapeutics (P&T) and Annual Radiation & Imaging Meeting in Dallas.
The LEAD Award was created by The US Oncology Network to honor life sciences companies for Leadership in Education And Clinical Development. Bristol-Myers Squibb is the first recipient of this award. Through the discovery, development and commercialization of immuno-oncology agents, BMS has set an example of commitment to research and clinical education—leveraging the broad capabilities of The US Oncology Network to bring these innovative medicines to patients.
Help employers find you! Check out all the jobs and post your resume.
The LEAD Award was created by The US Oncology Network to honor life sciences companies for Leadership in Education And Clinical Development. Bristol-Myers Squibb is the first recipient of this award. Through the discovery, development and commercialization of immuno-oncology agents, BMS has set an example of commitment to research and clinical education—leveraging the broad capabilities of The US Oncology Network to bring these innovative medicines to patients.
Help employers find you! Check out all the jobs and post your resume.